Display Settings:

Format

Send to:

Choose Destination
Lancet Infect Dis. 2010 May;10(5):305-16. doi: 10.1016/S1473-3099(10)70069-4.

Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference.

Author information

  • 1HIV Vaccine Research Unit, French National Agency for Research on AIDS and Viral Hepatitis, Paris, France.

Abstract

The search for an HIV/AIDS vaccine is steadily moving ahead, generating and validating new concepts in terms of novel vectors for antigen delivery and presentation, new vaccine and adjuvant strategies, alternative approaches to design HIV-1 antigens for eliciting protective cross-neutralising antibodies, and identification of key mechanisms in HIV infection and modulation of the immune system. All these different perspectives are contributing to the unprecedented challenge of developing a protective HIV-1 vaccine. The high scientific value of this massive effort is its great impact on vaccinology as a whole, providing invaluable scientific information for the current and future development of new preventive vaccine as well as therapeutic knowledge-based infectious-disease and cancer vaccines.

Copyright 2010 Elsevier Ltd. All rights reserved.

PMID:
20417413
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk